Prognostic Factors for Visual Outcomes Following the First Episode of NMOSD-Related Optic Neuritis in Affected Eyes [Corrigendum]

This article refers to:

Prognostic Factors for Visual Outcomes Following the First Episode of NMOSD-Related Optic Neuritis in Affected Eyes

Thongmee W, Padungkiatsagul T, Jindahra P, Khongkhatithum C, Thampratankul L, Vanikieti K. Clin Ophthalmol. 2020;14:4271–4278.

Table 5 on page 4276, the 95% CI and the p-value for the Time from initial ocular symptoms (pain and/or visual loss) to IVMP in each affected eye (days) row are incorrect.

Table 5 on page 4276, the 95% CI and the p-value for the BCVA at nadir better than CF row are incorrect.

The correct Table 5 is shown below.

Table 5 Univariate Analysis

Prognostic Factors	OR	95% CI	p-value
Time from initial ocular symptoms (pain and/or visual loss) to IVMP in each affected eye
• Less than 21 days	8.39	1.8, 38.9	0.007*
Time from initial ocular symptoms (pain and/or visual loss) to IVMP in each affected eye (days)	0.94	0.91, 0.98	0.04*
BCVA at nadir better than CF	8.00	0.94, 68.42	0.057

Note: *Statistically significant (p < 0.05).

Abbreviations: OR, odds ratio; CI, confidence interval; IVMP, intravenous methylprednisolone; BCVA, best-corrected visual acuity; CF, counting fingers.

The authors apologize for these errors and advise they do not affect the conclusions of the study.